These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 654174)

  • 1. [Antitumor action of cis-dichlorodiammineplatinum(II) and the effectiveness of a combination with sarcolysine].
    Presnov MA; Konovalova AL; Romanova LF; Sof'ina ZP; Stetsenko AI
    Vopr Onkol; 1978; 24(4):53-60. PubMed ID: 654174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of transplantable mouse tumors with cis-dichlorodiammineplatinum(II) alone and in combination with sarcolysin.
    Presnov MA; Konovalova AL; Romanova LF; Sofina ZP; Stetsenko AI
    Cancer Treat Rep; 1978 May; 62(5):705-12. PubMed ID: 657156
    [No Abstract]   [Full Text] [Related]  

  • 3. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the mechanism of action of complex copper (II) compounds with alpha-amino acids].
    Treshchalina EM; Matveĭchuk NV; Gudratov NO; Potapova GI
    Biull Eksp Biol Med; 1985 Jan; 99(1):86-8. PubMed ID: 4038465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
    Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L
    Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of the toxic effects of cis-dichlorodiammineplatinum].
    Kulik GI; Chekhun VF; Pel'kis FP; Korol' VI; Boĭm TM
    Eksp Onkol; 1985; 7(6):55-8. PubMed ID: 4085400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104E.
    Ghanta VK; Jones MT; Woodard DA; Durant JR; Hiramoto RN
    Cancer Res; 1977 Mar; 37(3):771-4. PubMed ID: 851480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of cis-dichlorodiammineplatinum(II).
    Wolpert-DeFilippes MK
    Cancer Treat Rep; 1979; 63(9-10):1453-8. PubMed ID: 498146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sarcolysine and 5-fluorouracil on the growth of transplanted tumors and on the reaction of the surrounding loose connective tissue].
    Iushkov SF; Rozenberg IB
    Farmakol Toksikol; 1971; 34(6):718-22. PubMed ID: 5139797
    [No Abstract]   [Full Text] [Related]  

  • 11. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between the effectiveness of the antitumor action of sarcolysine and the latency period between transplantation and tumor appearance].
    Gavrilova TN; Ladnova GG; Merkulov MF
    Biull Eksp Biol Med; 1978 Feb; 85(2):197-9. PubMed ID: 630096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of sarcolysin on H3-thymidine incorporation in loose connective tissue cells of mice with sarcoma 298 and adenocarcinoma 755].
    Rozenberg IB; Iushkov SF
    Farmakol Toksikol; 1972; 35(1):79-84. PubMed ID: 5011524
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
    Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of complex compounds of tetravalent platinum].
    Konovalova AL; Presnov MA; Zheligovskaia NN; Treshchalina EM
    Dokl Akad Nauk SSSR; 1977; 234(1):223-6. PubMed ID: 880861
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
    Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the antitumor properties and mechanism of action of kortifen].
    Lagova ND; Kiselev VI; Kurdiumova KN; Sof'ina ZP; Shkodinskaia EN
    Vopr Onkol; 1989; 35(4):450-6. PubMed ID: 2728387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.